文献速递心胸血管麻醉

心脏术后急性等容血液稀释对输血率影响的Meta分析

Acute normovolaemic haemodilution after cardiac surgery: a meta-analysis of randomised controlled trials.
PubMed 文献 · Br J Anaesth · 2026-01-19

该Meta分析纳入成人择期心脏手术的随机对照试验,评估急性等容血液稀释(ANH)是否减少术后住院期间异体红细胞输注比例。结果显示ANH组与标准组输血比例相似(40% vs 43%,RR 0.94,95%CI 0.85-1.02,P=0.15),但术后48小时内输血减少(RR 0.64,95%CI 0.48-0.84,P=0.001)。结论认为ANH未减少术后住院期间总体异体红细胞输注比例。

要点

  • ANH未显著降低心脏术后住院期间异体红细胞输注比例。
  • ANH可减少术后48小时内红细胞输注。
  • 两组手术再探查率和全因死亡率无差异。

核心结论

  • 急性等容血液稀释未减少心脏手术患者术后住院期间接受异体红细胞输注的比例。

研究设计与样本

  • 随机对照试验的Meta分析,纳入成人择期心脏手术患者,排除仅报告≤48小时观察期的试验。

主要发现

  • ANH组与标准组接受异体红细胞输注比例相似:755/1899(40%)vs 831/1914(43%),RR 0.94(95%CI 0.85-1.02),P=0.15,I2=80%。
  • 术后48小时内输血减少:RR 0.64(95%CI 0.48-0.84),P=0.001,I2=73%。
  • 手术再探查率无差异:RR 1.22(95%CI 0.91-1.65),P=0.18,I2=0%。
  • 全因死亡率无差异:RR 0.73(95%CI 0.43-1.24),P=0.25,I2=0%。

临床怎么用

  • ANH不应以降低整体住院输血率为主要目的用于心脏手术。
  • ANH或可减少术后早期(48小时内)异体红细胞输注。

局限性

  • 多数纳入试验因缺乏结局报告和盲法而存在中等偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute normovolaemic haemodilution (ANH) is a widely adopted packed red blood cells (pRBC) transfusion sparing strategy after cardiac surgery. While the intraoperative effect is plausible and likely enhanced by the lack of blinding, the effect on the overall in-hospital transfusion rate is unknown. We conducted a meta-analysis of randomised controlled trials to assess whether ANH reduced the proportion of cardiac surgery patients who received allogeneic pRBC transfusions during the postoperative hospital stay. METHODS: We searched for trials on ANH in adults undergoing elective cardiac surgery. The primary outcome was the number of patients receiving allogenic pRBC transfusions during the in-hospital postoperative period (excluding trials which solely reported observation period ≤48 h). Secondary outcomes included the number of patients transfused within 48 h after surgery, surgical revision, and all-cause mortality. RESULTS: The proportion of patients who received allogeneic pRBC transfusions was similar in the ANH and standard groups (755/1899 [40%] vs 831/1914 [43%]; risk ratio [RR] 0.94, 95% confidence interval, CI 0.85-1.02]; P=0.15; I2=80%), while they received fewer transfusions in the first 48 postoperative hours (RR 0.64, 95% CI [0.48-0.84]; P=0.001; I2=73%). There was no difference in surgical revision rate (RR 1.22, 95% CI [0.91-1.65]; P=0.18; I2=0%;), all-cause mortality (RR 0.73, 95% CI [0.43-1.24]; P=0.25; I2=0%), or other secondary outcomes. Most included trials had intermediate risk of bias because of lack of outcomes reporting and blinding. CONCLUSIONS: Acute normovolaemic haemodilution did not reduce the proportion of cardiac surgery patients who received allogeneic packed red blood cell transfusions during the postoperative hospital stay. This result should be interpreted considering the risk of bias of the included trials. Systematic review protocol. PROSPERO (CRD420251054530).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Pruna A, Oriani A, Monaco F, et al. Acute normovolaemic haemodilution after cardiac surgery: a meta-analysis of randomised controlled trials. Br J Anaesth. 2026. PMID: 41558891. doi:10.1016/j.bja.2025.11.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。